REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/24/2025
Back to search
Official data from USPTO
ALOFISEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/25/2025
Trademark type
Word
Nice classes
5
Filing date
09/05/2019
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2020
Last transaction
11/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CH
Examiner
O'BRIEN,JENNIFER LYNN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Takeda Pharmaceuticals International AG
TIGENIX, S.A.U.
Representatives
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of fistulasfistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients; cellularbiological or bacteriological preparations for medical purposesfor the treatment of fistulasfistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants or engineered live cellular tissue for medical purposesfor the treatment of fistulasfistulas in Crohn's disease patientscomplex perianal fistulas and complex perianal fistulas in Crohn's disease patients
Publications
History of USPTO decisions and trademark events.
33 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/28/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/28/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/12/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/26/2021
FIMP
FINAL DISPOSITION PROCESSED
02/26/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/24/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/08/2020
PUBO
PUBLISHED FOR OPPOSITION
09/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/19/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/01/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/01/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/01/2020
RFNT
REFUSAL PROCESSED BY IB
01/31/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2020
RFRR
REFUSAL PROCESSED BY MPU
01/13/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/14/2019
CNRT
NON-FINAL ACTION WRITTEN
12/13/2019
DOCK
ASSIGNED TO EXAMINER
12/06/2019
MAFR
APPLICATION FILING RECEIPT MAILED
10/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/15/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/10/2019
Continuous trademark protection
Get notified about every new filing that threatens ALOFISEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.